C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 39/395 (2006.01) C07K 14/00 (2006.01) C07K 14/435 (2006.01) C07K 14/705 (2006.01) C07K 16/18 (2006.01) C07K 16/28 (2006.01) C12N 15/63 (2006.01)
Patent
CA 2299619
The present invention provides for a nucleic acid sequence, designated as HUMAN NTR-1, that encodes a novel orphan receptor expressed in pancreas and fetal heart. The invention also provides assay systems that may be used to detect and/or measure ligands that bind the HUMAN NTR-1 gene product. The present invention also provides for diagnostic and therapeutic methods based on the interaction between NTR-1 and agents that initiate signal transduction through binding to NTR-1.
L'invention porte sur une séquence d'acide nucléique dite HUMAN NTR-1 codant pour un nouveau récepteur orphelin exprimé dans le pancréas et le coeur du foetus. L'invention porte également sur des systèmes d'essai pouvant servir à détecter ou mesurer les ligands se fixant au produit génique HUMAN NTR-1; elle porte en outre sur des procédés thérapeutiques basés sur l'interaction entre le NTR-1 et des agents provoquant la transduction de signaux en se fixant au NTR-1.
Masiakowski Piotr J.
Morris Jodi
Valenzuela David M.
Osler Hoskin & Harcourt Llp
Regeneron Pharmaceuticals Inc.
The Procter & Gamble Company
LandOfFree
Human orphan receptor ntr-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human orphan receptor ntr-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human orphan receptor ntr-1 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1948155